Profil Financier
George Yancopoulos occupe actuellement le rang #2446 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.7 B (-$396 sur 24h).
George Yancopoulos is the chief scientific officer of biotech firm Regeneron.
He received his M.D. and Ph.D. from Columbia University and became a professor of biology by age 28.
Regeneron was cofounded by now-billionaire Leonard Schleifer in 1988. Yancopoulos joined the next year.
Yancopoulos led the invention of eleven FDA-approved drugs and a technology platform designed to invent more.
Yancopoulos owns about 1% of Regeneron stock.
Yancopoulos was a finalist in the Westinghouse Science Talent Search in 1976. Today, it is called the Regeneron Science Talent Search and sponsored by his company.